Literature DB >> 6309814

Cyclic AMP treatment of Rous sarcoma virus-transformed Chinese hamster ovary cells increases phosphorylation of pp60src and increases pp60src kinase activity.

C W Roth, N D Richert, I Pastan, M M Gottesman.   

Abstract

Treatment of growing Rous sarcoma virus-transformed Chinese hamster ovary cells with the cyclic AMP analog 8-bromo-cyclic adenosine 3',5'-monophosphate (8-bromo-cyclic AMP) stimulates the incorporation of 32Pi into the viral transforming protein pp60src. Based on one-dimensional and two-dimensional peptide analysis and phosphoamino acid analysis, the increase is on a single phosphoserine residue at the NH2 terminus of the protein. The phosphate incorporation increases during the first 4 h of treatment. The pp60src kinase activity in extracts of cells treated with 8-bromo-cyclic AMP was stimulated about 2- to 3-fold. This stimulation of kinase activity increased during the first 3 h of treatment with 1 mM 8-bromo-cAMP and the activity was increased in both the soluble and particulate fraction of the cells. These results suggest that cyclic AMP can modulate the activity of pp60src in transformed cells.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6309814

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Dephosphorylation or antibody binding to the carboxy terminus stimulates pp60c-src.

Authors:  J A Cooper; C S King
Journal:  Mol Cell Biol       Date:  1986-12       Impact factor: 4.272

2.  Deletions and insertions within an amino-terminal domain of pp60v-src inactivate transformation and modulate membrane stability.

Authors:  H C Wang; J T Parsons
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

3.  Phosphorylation of the transforming protein of Rous sarcoma virus: direct demonstration of phosphorylation of serine 17 and identification of an additional site of tyrosine phosphorylation in p60v-src of Prague Rous sarcoma virus.

Authors:  T Patschinsky; T Hunter; B M Sefton
Journal:  J Virol       Date:  1986-07       Impact factor: 5.103

4.  Structural differences between repressed and derepressed forms of p60c-src.

Authors:  A MacAuley; J A Cooper
Journal:  Mol Cell Biol       Date:  1989-06       Impact factor: 4.272

5.  Attenuation of serum inducibility of immediate early genes by oncoproteins in tyrosine kinase signaling pathways.

Authors:  C L Yu; E V Prochownik; M J Imperiale; R Jove
Journal:  Mol Cell Biol       Date:  1993-04       Impact factor: 4.272

6.  Structurally and functionally modified forms of pp60v-src in Rous sarcoma virus-transformed cell lysates.

Authors:  M S Collett; S K Belzer; A F Purchio
Journal:  Mol Cell Biol       Date:  1984-07       Impact factor: 4.272

7.  Mutation of amino acids in pp60c-src that are phosphorylated by protein kinases C and A.

Authors:  P Yaciuk; J K Choi; D Shalloway
Journal:  Mol Cell Biol       Date:  1989-06       Impact factor: 4.272

8.  Regulation of the junB gene by v-src.

Authors:  I Apel; C L Yu; T Wang; C Dobry; M E Van Antwerp; R Jove; E V Prochownik
Journal:  Mol Cell Biol       Date:  1992-08       Impact factor: 4.272

9.  Substrate affinity of the protein tyrosine kinase pp60c-src is increased on thrombin stimulation of human platelets.

Authors:  U Liebenhoff; D Brockmeier; P Presek
Journal:  Biochem J       Date:  1993-10-01       Impact factor: 3.857

10.  Cholera toxin treatment stimulates tumorigenicity of Rous sarcoma virus-transformed cells.

Authors:  M M Gottesman; C Roth; G Vlahakis; I Pastan
Journal:  Mol Cell Biol       Date:  1984-12       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.